INBP

Integrated Biopharma INC

Insider trading activity for Integrated Biopharma INC, straight from SEC Form 4 filings. Net figures below count open-market buys and sales only — grants, option exercises and tax withholding are excluded because they are compensation, not decisions to trade.

Past 3 months

net buying

Bought(0 · 0 insiders): $0
Sold(0 · 0 insiders): $0

Past 6 months

net buying

Bought(0 · 0 insiders): $0
Sold(0 · 0 insiders): $0

Past 12 months

net buying

Bought(0 · 0 insiders): $0
Sold(0 · 0 insiders): $0

Transaction history

The 29 most recent Form 4 transactions.

Open in screener →

Insider transactions, newest first: date, security, transaction type, size and a link to the filing each row came from.
Date	Insider	Role	Type	Shares	Price	Value	Δ Own	Filing
Jun 24	Friedman Eric J	Director	AGRANT◆↺	50,000	—	—	—	Open the original filing on SEC.gov
Jun 24	Milmoe William H.	Director	AGRANT◆	50,000	—	—	—	Open the original filing on SEC.gov
Jun 24	DeSantis Damon	Director, 10% Owner	AGRANT◆	50,000	—	—	—	Open the original filing on SEC.gov
Jun 24	Canarick Robert	Director	AGRANT◆	50,000	—	—	—	Open the original filing on SEC.gov
Apr 15	Desantis Carl	10% Owner	GGIFT	2.2M	—	—	-100.0%	Open the original filing on SEC.gov
Apr 15	Desantis Carl	10% Owner	GGIFT	9M	—	—	-80.0%	Open the original filing on SEC.gov
Mar 24	Milmoe William H.	Director, 10% Owner	GGIFT	7,392	—	—	<0.1%	Open the original filing on SEC.gov
Mar 24	Milmoe William H.	Director, 10% Owner	GGIFT	1.4M	—	—	-10.5%	Open the original filing on SEC.gov
Mar 24	DeSantis Damon	Director	GGIFT	7,392	—	—	+0.5%	Open the original filing on SEC.gov
Mar 24	DeSantis Damon	Director	GGIFT	1.4M	—	—	—	Open the original filing on SEC.gov
Mar 24	Desantis Carl	10% Owner	GGIFT	7,392	—	—	<0.1%	Open the original filing on SEC.gov
Mar 24	Desantis Carl	10% Owner	GGIFT	1.4M	—	—	-10.7%	Open the original filing on SEC.gov
Dec 9, 2025	Masi Dina	Chief Financial Officer	AGRANT◆	140,000	—	—	—	Open the original filing on SEC.gov
Dec 9, 2025	Kay Christina	Co-Chief Executive…	AGRANT◆	140,000	—	—	—	Open the original filing on SEC.gov
Dec 9, 2025	Riva Sheppard	Co-Chief Executive…	AGRANT◆	140,000	—	—	—	Open the original filing on SEC.gov
Jun 18, 2025	Milmoe William H.	Director, 10% Owner	AGRANT◆	50,000	—	—	—	Open the original filing on SEC.gov
Jun 18, 2025	Friedman Eric J	Director	AGRANT◆	50,000	—	—	—	Open the original filing on SEC.gov
Jun 18, 2025	DeSantis Damon	Director	AGRANT◆	50,000	—	—	—	Open the original filing on SEC.gov
Jun 18, 2025	Canarick Robert	Director	AGRANT◆	50,000	—	—	—	Open the original filing on SEC.gov
May 30, 2025	Milmoe William H.	Director, 10% Owner	DTOISS◆	50,000	—	—	—	Open the original filing on SEC.gov
May 30, 2025	Milmoe William H.	Director, 10% Owner	AGRANT	50,000	$0.09	$4.5K	+56.4%	Open the original filing on SEC.gov
May 21, 2025	Riva Sheppard	Co-Chief Executive…	DTOISS◆	144,445	—	—	—	Open the original filing on SEC.gov
May 21, 2025	Riva Sheppard	Co-Chief Executive…	AGRANT	144,445	$0.09	$13K	+10.9%	Open the original filing on SEC.gov
May 21, 2025	Kay Christina	Co-Chief Executive…	DTOISS◆	144,445	—	—	—	Open the original filing on SEC.gov
May 21, 2025	Kay Christina	Co-Chief Executive…	AGRANT	144,445	$0.09	$13K	+10.9%	Open the original filing on SEC.gov
May 21, 2025	Masi Dina	Chief Financial Officer	DTOISS◆	135,000	—	—	—	Open the original filing on SEC.gov
May 21, 2025	Masi Dina	Chief Financial Officer	AGRANT	135,000	$0.09	$12.2K	+63.6%	Open the original filing on SEC.gov
May 21, 2025	Canarick Robert	Director	DTOISS◆	175,000	—	—	—	Open the original filing on SEC.gov
May 21, 2025	Canarick Robert	Director	AGRANT	175,000	$0.09	$15.8K	+295.4%	Open the original filing on SEC.gov

AGRANT◆↺—

Friedman Eric J · DirectorJun 24

50,000 sh

AGRANT◆—

Milmoe William H. · DirectorJun 24

50,000 sh

AGRANT◆—

DeSantis Damon · Director, 10%…Jun 24

50,000 sh

AGRANT◆—

Canarick Robert · DirectorJun 24

50,000 sh

GGIFT—

Desantis Carl · 10% OwnerApr 15

2.2M sh · -100.0% own

GGIFT—

Desantis Carl · 10% OwnerApr 15

9M sh · -80.0% own

GGIFT—

Milmoe William H. · Director, 10%…Mar 24

7,392 sh · <0.1% own

GGIFT—

Milmoe William H. · Director, 10%…Mar 24

1.4M sh · -10.5% own

GGIFT—

DeSantis Damon · DirectorMar 24

7,392 sh · +0.5% own

GGIFT—

DeSantis Damon · DirectorMar 24

1.4M sh

GGIFT—

Desantis Carl · 10% OwnerMar 24

7,392 sh · <0.1% own

GGIFT—

Desantis Carl · 10% OwnerMar 24

1.4M sh · -10.7% own

AGRANT◆—

Masi Dina · Chief Financial…Dec 9, 2025

140,000 sh

AGRANT◆—

Kay Christina · Co-Chief Executive…Dec 9, 2025

140,000 sh

AGRANT◆—

Riva Sheppard · Co-Chief Executive…Dec 9, 2025

140,000 sh

AGRANT◆—

Milmoe William H. · Director, 10%…Jun 18, 2025

50,000 sh

AGRANT◆—

Friedman Eric J · DirectorJun 18, 2025

50,000 sh

AGRANT◆—

DeSantis Damon · DirectorJun 18, 2025

50,000 sh

AGRANT◆—

Canarick Robert · DirectorJun 18, 2025

50,000 sh

DTOISS◆—

Milmoe William H. · Director, 10%…May 30, 2025

50,000 sh

AGRANT$4.5K

Milmoe William H. · Director, 10%…May 30, 2025

50,000 sh @ $0.09 · +56.4% own

DTOISS◆—

Riva Sheppard · Co-Chief Executive…May 21, 2025

144,445 sh

AGRANT$13K

Riva Sheppard · Co-Chief Executive…May 21, 2025

144,445 sh @ $0.09 · +10.9% own

DTOISS◆—

Kay Christina · Co-Chief Executive…May 21, 2025

144,445 sh

AGRANT$13K

Kay Christina · Co-Chief Executive…May 21, 2025

144,445 sh @ $0.09 · +10.9% own

DTOISS◆—

Masi Dina · Chief Financial…May 21, 2025

135,000 sh

AGRANT$12.2K

Masi Dina · Chief Financial…May 21, 2025

135,000 sh @ $0.09 · +63.6% own

DTOISS◆—

Canarick Robert · DirectorMay 21, 2025

175,000 sh

AGRANT$15.8K

Canarick Robert · DirectorMay 21, 2025

175,000 sh @ $0.09 · +295.4% own

Filing record

How quickly insiders here report their trades. Section 16 allows two business days from the transaction.

All 18 filings we hold were filed within the two-business-day deadline.

Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings

Insiders at this company

Everyone who has filed a Form 4 for this issuer.

More biotech & pharma companies

Other issuers in the same industry with insider filings on record.

Whole sector →